Aspect Biosystems $280M Partnership with Canada for Cell Medicines
Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicines Aspect Biosystems, a biotechnology company pioneering a novel...